Total Payments
$2,257
2024 Payments
$388.28
Companies
8
Transactions
37
Medicare Patients
146
Medicare Billing
$16,770
Payment Breakdown by Category
Food & Beverage$2,257 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,257 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,089 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $471.36 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $310.05 | 16 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $142.20 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $125.00 | 1 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $67.93 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $26.25 | 1 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $24.87 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $388.28 | 10 | Abbott Laboratories ($127.21) |
| 2023 | $1,102 | 13 | Abbott Laboratories ($492.23) |
| 2022 | $659.55 | 9 | Abbott Laboratories ($469.96) |
| 2021 | $106.74 | 5 | Novartis Pharmaceuticals Corporation ($80.49) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Genetic Disease | ||||||
| 10/23/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardiology | ||||||
| 07/30/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/09/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $127.21 | General |
| Category: Heart Failure | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $142.96 | General |
| Category: Heart Failure | ||||||
| 11/16/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 10/05/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/11/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/28/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/05/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Heart Failure | ||||||
| 04/13/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $154.35 | General |
| Category: Heart Failure | ||||||
| 03/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/11/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $165.55 | General |
| Category: Heart Failure | ||||||
| 02/08/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/29/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $100.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 40 | $23,868 | $3,224 |
| 2022 | 1 | 21 | 25 | $17,225 | $2,522 |
| 2021 | 3 | 70 | 78 | $40,668 | $9,012 |
| 2020 | 1 | 20 | 23 | $10,925 | $2,012 |
Total Patients
146
Total Services
166
Medicare Billing
$16,770
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 27 | $18,603 | $2,290 | 12.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $5,265 | $933.79 | 17.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 25 | $17,225 | $2,522 | 14.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 29 | $18,589 | $4,321 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 36 | $17,100 | $3,703 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 13 | $4,979 | $988.00 | 19.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 20 | 23 | $10,925 | $2,012 | 18.4% |
About Allison Provenzale, ACNP
Allison Provenzale, ACNP is a Acute Care healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2017. The National Provider Identifier (NPI) number assigned to this provider is 1033636709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Provenzale, ACNP has received a total of $2,257 in payments from pharmaceutical and medical device companies, with $388.28 received in 2024. These payments were reported across 37 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($2,257).
As a Medicare-enrolled provider, Provenzale has provided services to 146 Medicare beneficiaries, totaling 166 services with total Medicare billing of $16,770. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Manhasset, NY
- Active Since 08/24/2017
- Last Updated 08/24/2017
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1033636709
Products in Payments
- CARDIOMEMS (Device) $894.72
- FARXIGA (Drug) $471.36
- ENTRESTO (Drug) $272.56
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $194.68
- FUROSCIX (Drug) $142.20
- VERQUVO (Drug) $125.00
- Inpefa (Drug) $67.93
- LEQVIO (Drug) $37.49
- XARELTO (Drug) $26.25
- AMVUTTRA (Drug) $24.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Manhasset
Alisha Mattondo
Acute Care — Payments: $9,120
Acute Care $9,120
Mrs. Kathleen Davidson, Np, NP
Acute Care — Payments: $3,333
Acute Care $3,333
Gary Plotkin, Np, NP
Acute Care — Payments: $1,716
Acute Care $1,716
Yuson Chong, Np, NP
Acute Care — Payments: $1,399
Acute Care $1,399
Mrs. Rowena Amistad, Np, NP
Acute Care — Payments: $899.98
Acute Care $899.98
Jing Lee, Np, NP
Acute Care — Payments: $596.47
Acute Care $596.47